1. Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol. 2008; 6:815–826. [PubMed: 18923409]
2. Mothes W, Sherer NM, Jin J, Zhong P. Virus cell-to-cell transmission. J Virol. 2010; 84:8360–8368. [PubMed: 20375157]
3. Jolly C. T cell polarization at the virological synapse. Viruses. 2010; 2:1261–1278. [PubMed: 21994679]
4. Fackler OT, Murooka TT, Imle A, Mempel TR. Adding new dimensions: towards an integrative understanding of HIV-1 spread. Nat Rev Microbiol. 2014; 12:563–574. [PubMed: 25029025]
5. Alvarez RA, Barria MI, Chen BK. Unique features of HIV-1 spread through T cell virological synapses. PLoS Pathog. 2014; 10:e1004513. [PubMed: 25522148]
6. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M, Bangham CR. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science. 2003; 299:1713–1716. [PubMed: 12589003] • Together with Jolly et al. [7], this study establishes the concept of the virological synapse.
7. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med. 2004; 199:283–293. [PubMed: 14734528] • Together with Igakura et al. [6], this study establishes the concept of the virological synapse.
8. Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K, Steinman RM. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science. 1992; 257:383–387. [PubMed: 1352913] • Together with McDonald et al. [9], this study introduces the concept of trans-infection.
9. McDonald D, Wu L, Bohks SM, KewalRamani VN, Unutmaz D, Hope TJ. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science. 2003; 300:1295–1297. [PubMed: 12730499] • Together with Cameron et al. [8], this study introduces the concept of trans-infection and establishes the model of the infectious synapse.
10. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, Mothes W. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat Cell Biol. 2007; 9:310–315. [PubMed: 17293854] • Together with Hubner et al. [11], this study visualizes the transfer of retrovirus particles across cell-cell contacts in tissue culture cells.
11. Hubner W, McNerney GP, Chen P, Dale BM, Gordon RE, Chuang FY, Li XD, Asmuth DM, Huser T, Chen BK. Quantitative 3D video microscopy of HIV transfer across T cell virological synapses. Science. 2009; 323:1743–1747. [PubMed: 19325119] • Together with Sherer et al. [10], this study visualizes the transfer of retrovirus particles across cell-cell contacts in tissue culture cells.
12. Jin J, Sherer NM, Heidecker G, Derse D, Mothes W. Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol. 2009; 7:e1000163. [PubMed: 19636361] • This study demonstrates polarized virus assembly at virological synapses.
13. Groot F, Welsch S, Sattentau QJ. Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood. 2008; 111:4660–4663. [PubMed: 18296630]
14. Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, Nagashima K, Ott DE, Freed EO. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 2008; 4:e1000015. [PubMed: 18369466]
Sewald et al. Page 7
Curr Opin Cell Biol. Author manuscript; available in PMC 2017 August 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
15. Sewald X, Ladinsky MS, Uchil PD, Beloor J, Pi R, Herrmann C, Motamedi N, Murooka TT, Brehm MA, Greiner DL, et al. Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science. 2015; 350:563–567. [PubMed: 26429886] •• This study demonstrates the key concept of contact-dependent trans-infection in vivo.
16. Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013; 13:379–393. [PubMed: 23601101]
17. Taylor MP, Enquist LW. Axonal spread of neuroinvasive viral infections. Trends Microbiol. 2015; 23:283–288. [PubMed: 25639651]
18. Cabrera JR, Viejo-Borbolla A, Martinez-Martin N, Blanco S, Wandosell F, Alcami A. Secreted herpes simplex virus-2 glycoprotein G modifies NGF-TrkA signaling to attract free nerve endings to the site of infection. PLoS Pathog. 2015; 11:e1004571. [PubMed: 25611061]
19. Abaitua F, Zia FR, Hollinshead M, O'Hare P. Polarized cell migration during cell-to-cell transmission of herpes simplex virus in human skin keratinocytes. J Virol. 2013; 87:7921–7932. [PubMed: 23658449]
20. Chen P, Hubner W, Spinelli MA, Chen BK. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses. J Virol. 2007; 81:12582–12595. [PubMed: 17728240]
21. Feldmann J, Schwartz O. HIV-1 Virological Synapse: Live Imaging of Transmission. Viruses. 2010; 2:1666–1680. [PubMed: 21994700]
22. Phillips DM. The role of cell-to-cell transmission in HIV infection. AIDS. 1994; 8:719–731. [PubMed: 8086128]
23. Koethe S, Avota E, Schneider-Schaulies S. Measles virus transmission from dendritic cells to T cells: formation of synapse-like interfaces concentrating viral and cellular components. J Virol. 2012; 86:9773–9781. [PubMed: 22761368]
24. Aubert M, Yoon M, Sloan DD, Spear PG, Jerome KR. The virological synapse facilitates herpes simplex virus entry into T cells. J Virol. 2009; 83:6171–6183. [PubMed: 19339346]
25. Rudnicka D, Feldmann J, Porrot F, Wietgrefe S, Guadagnini S, Prevost MC, Estaquier J, Haase AT, Sol-Foulon N, Schwartz O. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses. J Virol. 2009; 83:6234–6246. [PubMed: 19369333]
26. Dustin ML, Colman DR. Neural and immunological synaptic relations. Science. 2002; 298:785–789. [PubMed: 12399580]
27. Huppa JB, Davis MM. T-cell-antigen recognition and the immunological synapse. Nat Rev Immunol. 2003; 3:973–983. [PubMed: 14647479]
28. Vasiliver-Shamis G, Tuen M, Wu TW, Starr T, Cameron TO, Thomson R, Kaur G, Liu J, Visciano ML, Li H, et al. Human immunodeficiency virus type 1 envelope gp120 induces a stop signal and virological synapse formation in noninfected CD4+ T cells. J Virol. 2008; 82:9445–9457. [PubMed: 18632854]
29. Vasiliver-Shamis G, Cho MW, Hioe CE, Dustin ML. Human immunodeficiency virus type-1 envelope gp120-induced partial T-cell receptor signaling creates an F-actin-depleted zone in the virological synapse. J Virol. 2009; 83:11341–11355. [PubMed: 19710135]
30. Hioe CE, Tuen M, Vasiliver-Shamis G, Alvarez Y, Prins KC, Banerjee S, Nadas A, Cho MW, Dustin ML, Kachlany SC. HIV envelope gp120 activates LFA-1 on CD4 T-lymphocytes and increases cell susceptibility to LFA-1-targeting leukotoxin (LtxA). PLoS One. 2011; 6:e23202. [PubMed: 21850260]
31. Sol-Foulon N, Sourisseau M, Porrot F, Thoulouze MI, Trouillet C, Nobile C, Blanchet F, di Bartolo V, Noraz N, Taylor N, et al. ZAP-70 kinase regulates HIV cell-to-cell spread and virological synapse formation. EMBO J. 2007; 26:516–526. [PubMed: 17215865]
32. Nejmeddine M, Negi VS, Mukherjee S, Tanaka Y, Orth K, Taylor GP, Bangham CR. HTLV-1-Tax and ICAM-1 act on T-cell signal pathways to polarize the microtubule-organizing center at the virological synapse. Blood. 2009; 114:1016–1025. [PubMed: 19494354]
33. Li F, Jin J, Herrmann C, Mothes W. Basic residues in the matrix domain and multimerization target murine leukemia virus Gag to the virological synapse. J Virol. 2013; 87:7113–7126. [PubMed: 23616653]
Sewald et al. Page 8
Curr Opin Cell Biol. Author manuscript; available in PMC 2017 August 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
34. Jolly C, Mitar I, Sattentau QJ. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J Virol. 2007; 81:5547–5560. [PubMed: 17360745]
35. Jolly C, Welsch S, Michor S, Sattentau QJ. The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Pathog. 2011; 7:e1002226. [PubMed: 21909273]
36. Groppelli E, Starling S, Jolly C. Contact-induced mitochondrial polarization supports HIV-1 virological synapse formation. J Virol. 2015; 89:14–24. [PubMed: 25320323]
37. Do T, Murphy G, Earl LA, Del Prete GQ, Grandinetti G, Li GH, Estes JD, Rao P, Trubey CM, Thomas J, et al. Three-dimensional imaging of HIV-1 virological synapses reveals membrane architectures involved in virus transmission. J Virol. 2014; 88:10327–10339. [PubMed: 24965444]
38. Martin N, Welsch S, Jolly C, Briggs JA, Vaux D, Sattentau QJ. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. Journal of virology. 2010; 84:3516–3527. [PubMed: 20089656]
39. Choudhuri K, Llodra J, Roth EW, Tsai J, Gordo S, Wucherpfennig KW, Kam LC, Stokes DL, Dustin ML. Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature. 2014; 507:118–123. [PubMed: 24487619]
40. Nikolic DS, Lehmann M, Felts R, Garcia E, Blanchet FP, Subramaniam S, Piguet V. HIV-1 activates Cdc42 and induces membrane extensions in immature dendritic cells to facilitate cell-to-cell virus propagation. Blood. 2011; 118:4841–4852. [PubMed: 21562048]
41. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000; 100:587–597. [PubMed: 10721995]
42. Turville SG, Cameron PU, Handley A, Lin G, Pohlmann S, Doms RW, Cunningham AL. Diversity of receptors binding HIV on dendritic cell subsets. Nat Immunol. 2002; 3:975–983. [PubMed: 12352970]
43. Izquierdo-Useros N, Lorizate M, Contreras FX, Rodriguez-Plata MT, Glass B, Erkizia I, Prado JG, Casas J, Fabrias G, Krausslich HG, et al. Sialyllactose in viral membrane gangliosides is a novel molecular recognition pattern for mature dendritic cell capture of HIV-1. PLoS Biol. 2012; 10:e1001315. [PubMed: 22545022] • Together with Izquierdo-Useros et al. and Puryear et al. [44, 45, 46], these 4 studies identify the lectin CD169 on monocyte-derived dendritic cells to bind gangliosides within the retrovirus envelope for trans-infection.
44. Izquierdo-Useros N, Lorizate M, Puertas MC, Rodriguez-Plata MT, Zangger N, Erikson E, Pino M, Erkizia I, Glass B, Clotet B, et al. Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides. PLoS Biol. 2012; 10:e1001448. [PubMed: 23271952] • See annotation to Ref. [43].
45. Puryear WB, Yu X, Ramirez NP, Reinhard BM, Gummuluru S. HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells. Proc Natl Acad Sci U S A. 2012; 109:7475–7480. [PubMed: 22529395] • See annotation to Ref. [43].
46. Puryear WB, Akiyama H, Geer SD, Ramirez NP, Yu X, Reinhard BM, Gummuluru S. Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. PLoS Pathog. 2013; 9:e1003291. [PubMed: 23593001] • See annotation to Ref. [43].
47. Akiyama H, Ramirez NG, Gudheti MV, Gummuluru S. CD169-mediated trafficking of HIV to plasma membrane invaginations in dendritic cells attenuates efficacy of anti-gp120 broadly neutralizing antibodies. PLoS Pathog. 2015; 11:e1004751. [PubMed: 25760631]
48. Rempel H, Calosing C, Sun B, Pulliam L. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS One. 2008; 3:e1967. [PubMed: 18414664]
49. Erikson E, Wratil PR, Frank M, Ambiel I, Pahnke K, Pino M, Azadi P, Izquierdo-Useros N, Martinez-Picado J, Meier C, et al. Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner. J Biol Chem. 2015; 290:27345–27359. [PubMed: 26370074]
50. Pino M, Erkizia I, Benet S, Erikson E, Fernandez-Figueras MT, Guerrero D, Dalmau J, Ouchi D, Rausell A, Ciuffi A, et al. HIV-1 immune activation induces Siglec-1 expression and enhances
Sewald et al. Page 9
Curr Opin Cell Biol. Author manuscript; available in PMC 2017 August 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
viral trans-infection in blood and tissue myeloid cells. Retrovirology. 2015; 12:37. [PubMed: 25947229]
51. Yu HJ, Reuter MA, McDonald D. HIV traffics through a specialized, surface-accessible intracellular compartment during trans-infection of T cells by mature dendritic cells. PLoS Pathog. 2008; 4:e1000134. [PubMed: 18725936]
52. Wang JH, Kwas C, Wu L. Intercellular adhesion molecule 1 (ICAM-1), but not ICAM-2 and -3, is important for dendritic cell-mediated human immunodeficiency virus type 1 transmission. J Virol. 2009; 83:4195–4204. [PubMed: 19211748]
53. Wang JH, Wells C, Wu L. Macropinocytosis and cytoskeleton contribute to dendritic cell-mediated HIV-1 transmission to CD4+ T cells. Virology. 2008; 381:143–154. [PubMed: 18804253]
54. Aggarwal A, Iemma TL, Shih I, Newsome TP, McAllery S, Cunningham AL, Turville SG. Mobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cells. PLoS pathogens. 2012; 8:e1002762. [PubMed: 22685410]
55. Menager MM, Littman DR. Actin dynamics regulates dendritic cell-mediated transfer of HIV-1 to T cells. Cell. 2016; 164:695–709. [PubMed: 26830877]
56. Felts RL, Narayan K, Estes JD, Shi D, Trubey CM, Fu J, Hartnell LM, Ruthel GT, Schneider DK, Nagashima K, et al. 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A. 2010; 107:13336–13341. [PubMed: 20624966]
57. Joseph SB, Arrildt KT, Sturdevant CB, Swanstrom R. HIV-1 target cells in the CNS. J Neurovirol. 2015; 21:276–289. [PubMed: 25236812]
58. Peters PJ, Bhattacharya J, Hibbitts S, Dittmar MT, Simmons G, Bell J, Simmonds P, Clapham PR. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol. 2004; 78:6915–6926. [PubMed: 15194768]
59. Thomas ER, Dunfee RL, Stanton J, Bogdan D, Taylor J, Kunstman K, Bell JE, Wolinsky SM, Gabuzda D. Macrophage entry mediated by HIV Envs from brain and lymphoid tissues is determined by the capacity to use low CD4 levels and overall efficiency of fusion. Virology. 2007; 360:105–119. [PubMed: 17084877]
60. Baxter AE, Russell RA, Duncan CJ, Moore MD, Willberg CB, Pablos JL, Finzi A, Kaufmann DE, Ochsenbauer C, Kappes JC, Groot F, Sattentau QJ. Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host Microbe. 2014; 16:711–721. [PubMed: 25467409]
61. Sattentau QJ, Stevenson M. Macrophages and HIV-1: An Unhealthy Constellation. Cell Host Microbe. 2016; 19:304–310. [PubMed: 26962941]
62. Bird SW, Kirkegaard K. Escape of non-enveloped virus from intact cells. Virology. 2015; 479–480:444–449.
63. Jackson WT, Giddings TH Jr, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, Kirkegaard K. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS biology. 2005; 3:e156. [PubMed: 15884975]
64. Feng Z, Hensley L, McKnight KL, Hu F, Madden V, Ping L, Jeong SH, Walker C, Lanford RE, Lemon SM. A pathogenic picornavirus acquires an envelope by hijacking cellular membranes. Nature. 2013; 496:367–371. [PubMed: 23542590] • The study shows that eHAV is a distinct version of the virus that carries a pseudo-membrane, has a distinct capsid protein and is sensitive to solvent-treatment.
65. Takahashi M, Tanaka T, Takahashi H, Hoshino Y, Nagashima S, Jirintai, Mizuo H, Yazaki Y, Takagi T, Azuma M, et al. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol. 2010; 48:1112–1125. [PubMed: 20107086]
66. Bird SW, Maynard ND, Covert MW, Kirkegaard K. Nonlytic viral spread enhanced by autophagy components. Proc Natl Acad Sci U S A. 2014; 111:13081–13086. [PubMed: 25157142] • This study describes how induction of autophagy by chemical compounds can increase non-lytic release of poliovirus.
67. Clayson ET, Brando LV, Compans RW. Release of simian virus 40 virions from epithelial cells is polarized and occurs without cell lysis. J Virol. 1989; 63:2278–2288. [PubMed: 2539518]
Sewald et al. Page 10
Curr Opin Cell Biol. Author manuscript; available in PMC 2017 August 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
68. Tucker SP, Thornton CL, Wimmer E, Compans RW. Vectorial release of poliovirus from polarized human intestinal epithelial cells. J Virol. 1993; 67:4274–4282. [PubMed: 8389927]
69. Chen YH, Du W, Hagemeijer MC, Takvorian PM, Pau C, Cali A, Brantner CA, Stempinski ES, Connelly PS, Ma HC, et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell. 2015; 160:619–630. [PubMed: 25679758]
70. Taylor MP, Burgon TB, Kirkegaard K, Jackson WT. Role of microtubules in extracellular release of poliovirus. J Virol. 2009; 83:6599–6609. [PubMed: 19369338]
71. Wirblich C, Bhattacharya B, Roy P. Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol. 2006; 80:460–473. [PubMed: 16352570]
72. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol. 1993; 67:2182–2190. [PubMed: 8445728]
73. Carr JM, Hocking H, Li P, Burrell CJ. Rapid and efficient cell-to-cell transmission of human immunodeficiency virus infection from monocyte-derived macrophages to peripheral blood lymphocytes. Virology. 1999; 265:319–329. [PubMed: 10600603]
74. Zhong P, Agosto LM, Ilinskaya A, Dorjbal B, Truong R, Derse D, Uchil PD, Heidecker G, Mothes W. Cell-to-cell transmission can overcome multiple donor and target cell barriers imposed on cell-free HIV. PLoS One. 2013; 8:e53138. [PubMed: 23308151]
75. Richardson MW, Carroll RG, Stremlau M, Korokhov N, Humeau LM, Silvestri G, Sodroski J, Riley JL. Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. Journal of virology. 2008; 82:11117–11128. [PubMed: 18768965]
76. Jolly C, Booth NJ, Neil SJ. Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells. Journal of virology. 2010; 84:12185–12199. [PubMed: 20861257]
77. Zhong P, Agosto LM, Munro JB, Mothes W. Cell-to-cell transmission of viruses. Current opinion in virology. 2013; 3:44–50. [PubMed: 23219376]
78. Malbec M, Porrot F, Rua R, Horwitz J, Klein F, Halper-Stromberg A, Scheid JF, Eden C, Mouquet H, Nussenzweig MC, et al. Broadly neutralizing antibodies that inhibit HIV-1 cell to cell transmission. J Exp Med. 2013; 210:2813–2821. [PubMed: 24277152]
79. Abela IA, Berlinger L, Schanz M, Reynell L, Gunthard HF, Rusert P, Trkola A. Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies. PLoS Pathog. 2012; 8:e1002634. [PubMed: 22496655]
80. Duncan CJ, Williams JP, Schiffner T, Gartner K, Ochsenbauer C, Kappes J, Russell RA, Frater J, Sattentau QJ. High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse. J Virol. 2014; 88:2025–2034. [PubMed: 24307588]
81. Reh L, Magnus C, Schanz M, Weber J, Uhr T, Rusert P, Trkola A. Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent. PLoS Pathog. 2015; 11:e1004966. [PubMed: 26158270]
82. Russell RA, Martin N, Mitar I, Jones E, Sattentau QJ. Multiple proviral integration events after virological synapse-mediated HIV-1 spread. Virology. 2013; 443:143–149. [PubMed: 23722103]
83. Del Portillo A, Tripodi J, Najfeld V, Wodarz D, Levy DN, Chen BK. Multiploid inheritance of HIV-1 during cell-to-cell infection. J Virol. 2011; 85:7169–7176. [PubMed: 21543479] • First experimental demonstration of the high multiplicity of infection during HIV-1 cell-to-cell transmission.
84. Agosto LM, Zhong P, Munro J, Mothes W. Highly active antiretroviral therapies are effective against HIV-1 cell-to-cell transmission. PLoS Pathog. 2014; 10:e1003982. [PubMed: 24586176]
85. Sigal A, Kim JT, Balazs AB, Dekel E, Mayo A, Milo R, Baltimore D. Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy. Nature. 2011; 477:95–98. [PubMed: 21849975]
86. Doitsh G, Cavrois M, Lassen KG, Zepeda O, Yang Z, Santiago ML, Hebbeler AM, Greene WC. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell. 2010; 143:789–801. [PubMed: 21111238]
Sewald et al. Page 11
Curr Opin Cell Biol. Author manuscript; available in PMC 2017 August 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
87. Doitsh G, Galloway NL, Geng X, Yang Z, Monroe KM, Zepeda O, Hunt PW, Hatano H, Sowinski S, Munoz-Arias I, et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature. 2014; 505:509–514. [PubMed: 24356306]
88. Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature. 2013; 498:376–379. [PubMed: 23739328]
89. Galloway NL, Doitsh G, Monroe KM, Yang Z, Munoz-Arias I, Levy DN, Greene WC. Cell-to-Cell Transmission of HIV-1 Is Required to Trigger Pyroptotic Death of Lymphoid-Tissue-Derived CD4 T Cells. Cell Rep. 2015; 12:1555–1563. [PubMed: 26321639]
90. Swartz MA. The physiology of the lymphatic system. Adv Drug Deliv Rev. 2001; 50:3–20. [PubMed: 11489331]
91. Iannacone M, Moseman EA, Tonti E, Bosurgi L, Junt T, Henrickson SE, Whelan SP, Guidotti LG, von Andrian UH. Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus. Nature. 2010; 465:1079–1083. [PubMed: 20577213]
92. Farrell HE, Davis-Poynter N, Bruce K, Lawler C, Dolken L, Mach M, Stevenson PG. Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination. J Virol. 2015; 89:7147–7158. [PubMed: 25926638]
93. Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, Shresta S. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J Virol. 2012; 86:12138–12147. [PubMed: 22933295]
94. Winkelmann ER, Widman DG, Xia J, Johnson AJ, van Rooijen N, Mason PW, Bourne N, Milligan GN. Subcapsular sinus macrophages limit dissemination of West Nile virus particles after inoculation but are not essential for the development of West Nile virus-specific T cell responses. Virology. 2014; 450–451:278–289.
95. Hickman HD, Takeda K, Skon CN, Murray FR, Hensley SE, Loomis J, Barber GN, Bennink JR, Yewdell JW. Direct priming of antiviral CD8+ T cells in the peripheral interfollicular region of lymph nodes. Nat Immunol. 2008; 9:155–165. [PubMed: 18193049]
96. Frederico B, Chao B, May JS, Belz GT, Stevenson PG. A murid gamma-herpesviruses exploits normal splenic immune communication routes for systemic spread. Cell host & microbe. 2014; 15:457–470. [PubMed: 24721574]
97. Frederico B, Chao B, Lawler C, May JS, Stevenson PG. Subcapsular sinus macrophages limit acute gammaherpesvirus dissemination. J Gen Virol. 2015; 96:2314–2327. [PubMed: 25872742]
98. Murooka TT, Deruaz M, Marangoni F, Vrbanac VD, Seung E, von Andrian UH, Tager AM, Luster AD, Mempel TR. HIV-infected T cells are migratory vehicles for viral dissemination. Nature. 2012; 490:283–287. [PubMed: 22854780] •• Together with Daley-Bauer et al. [99], this study documents that viruses use migrating cells as vehicles for systemic spread in vivo.
99. Daley-Bauer LP, Roback LJ, Wynn GM, Mocarski ES. Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microbe. 2014; 15:351–362. [PubMed: 24629341] •• See annotation to Ref. [98].
100. Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol. 2005; 5:617–628. [PubMed: 16056255]
101. Villablanca EJ, Mora JR. A two-step model for Langerhans cell migration to skin-draining LN. Eur J Immunol. 2008; 38:2975–2980. [PubMed: 18991275]
102. Cunningham AL, Abendroth A, Jones C, Nasr N, Turville S. Viruses and Langerhans cells. Immunol Cell Biol. 2010; 88:416–423. [PubMed: 20445632]
103. Roozendaal R, Mempel TR, Pitcher LA, Gonzalez SF, Verschoor A, Mebius RE, von Andrian UH, Carroll MC. Conduits mediate transport of low-molecular-weight antigen to lymph node follicles. Immunity. 2009; 30:264–276. [PubMed: 19185517]
104. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. Lymph-borne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J Exp Med. 2000; 192:1425–1440. [PubMed: 11085745]
Sewald et al. Page 12
Curr Opin Cell Biol. Author manuscript; available in PMC 2017 August 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
105. Sixt M, Kanazawa N, Selg M, Samson T, Roos G, Reinhardt DP, Pabst R, Lutz MB, Sorokin L. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity. 2005; 22:19–29. [PubMed: 15664156]
106. Gray EE, Cyster JG. Lymph node macrophages. J Innate Immun. 2012; 4:424–436. [PubMed: 22488251]
107. Chang JE, Turley SJ. Stromal infrastructure of the lymph node and coordination of immunity. Trends Immunol. 2015; 36:30–39. [PubMed: 25499856]
108. Kuka M, Iannacone M. The role of lymph node sinus macrophages in host defense. Ann N Y Acad Sci. 2014; 1319:38–46. [PubMed: 24592818]
109. Kraal G, Mebius R. New insights into the cell biology of the marginal zone of the spleen. Int Rev Cytol. 2006; 250:175–215. [PubMed: 16861066]
110. Saunderson SC, Dunn AC, Crocker PR, McLellan AD. CD169 mediates the capture of exosomes in spleen and lymph node. Blood. 2014; 123:208–216. [PubMed: 24255917]
111. Chan R, Uchil PD, Jin J, Shui G, Ott DE, Mothes W, Wenk MR. Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. Journal of virology. 2008; 82:11228–11238. [PubMed: 18799574]
112. Bennett AE, Narayan K, Shi D, Hartnell LM, Gousset K, He H, Lowekamp BC, Yoo TS, Bliss D, Freed EO, et al. Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS Pathog. 2009; 5:e1000591. [PubMed: 19779568]
113. Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol. 2007; 177:329–341. [PubMed: 17438075]
114. Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, Blanco J, Borras FE, Puertas MC, Connor JH, Fernandez-Figueras MT, et al. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood. 2009; 113:2732–2741. [PubMed: 18945959]
115. Sewald X, Gonzalez DG, Haberman AM, Mothes W. In vivo imaging of virological synapses. Nat Commun. 2012; 3:1320. [PubMed: 23271654]
116. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, Melroe H, Cavert W, Gebhard K, Staskus K, Zhang ZQ, et al. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science. 1996; 274:985–989. [PubMed: 8875941]
117. Ho J, Moir S, Kulik L, Malaspina A, Donoghue ET, Miller NJ, Wang W, Chun TW, Fauci AS, Holers VM. Role for CD21 in the establishment of an extracellular HIV reservoir in lymphoid tissues. J Immunol. 2007; 178:6968–6974. [PubMed: 17513746]
118. Smith BA, Gartner S, Liu Y, Perelson AS, Stilianakis NI, Keele BF, Kerkering TM, Ferreira-Gonzalez A, Szakal AK, Tew JG, et al. Persistence of infectious HIV on follicular dendritic cells. J Immunol. 2001; 166:690–696. [PubMed: 11123354]
119. Banki Z, Kacani L, Rusert P, Pruenster M, Wilflingseder D, Falkensammer B, Stellbrink HJ, van Lunzen J, Trkola A, Dierich MP, et al. Complement dependent trapping of infectious HIV in human lymphoid tissues. AIDS. 2005; 19:481–486. [PubMed: 15764853]
120. Banki Z, Wilflingseder D, Ammann CG, Pruenster M, Mullauer B, Hollander K, Meyer M, Sprinzl GM, van Lunzen J, Stellbrink HJ, et al. Factor I-mediated processing of complement fragments on HIV immune complexes targets HIV to CR2-expressing B cells and facilitates B cell-mediated transmission of opsonized HIV to T cells. J Immunol. 2006; 177:3469–3476. [PubMed: 16920989]
121. Ebenbichler CF, Thielens NM, Vornhagen R, Marschang P, Arlaud GJ, Dierich MP. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J Exp Med. 1991; 174:1417–1424. [PubMed: 1744579]
122. Joling P, Bakker LJ, Van Strijp JA, Meerloo T, de Graaf L, Dekker ME, Goudsmit J, Verhoef J, Schuurman HJ. Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent. J Immunol. 1993; 150:1065–1073. [PubMed: 8423332]
123. Moir S, Malaspina A, Li Y, Chun TW, Lowe T, Adelsberger J, Baseler M, Ehler LA, Liu S, Davey RT Jr, et al. B cells of HIV-1-infected patients bind virions through CD21-complement
Sewald et al. Page 13
Curr Opin Cell Biol. Author manuscript; available in PMC 2017 August 01.
Author Manuscript Author Manuscript Author Manuscript Author Manuscript
interactions and transmit infectious virus to activated T cells. J Exp Med. 2000; 192:637–646. [PubMed: 10974030] • See annotation to Ref. [124].
124. Heesters BA, Lindqvist M, Vagefi PA, Scully EP, Schildberg FA, Altfeld M, Walker BD, Kaufmann DE, Carroll MC. Follicular Dendritic Cells Retain Infectious HIV in Cycling Endosomes. PLoS Pathog. 2015; 11:e1005285. [PubMed: 26623655] • Together with Moir et al. [123], this study demonstrates that isolated follicular dendritic cells and B cells can store HIV for CD21-dependent trans-infection of T cells.
125. Kacani L, Prodinger WM, Sprinzl GM, Schwendinger MG, Spruth M, Stoiber H, Dopper S, Steinhuber S, Steindl F, Dierich MP. Detachment of human immunodeficiency virus type 1 from germinal centers by blocking complement receptor type 2. J Virol. 2000; 74:7997–8002. [PubMed: 10933708]
126. Phan TG, Grigorova I, Okada T, Cyster JG. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol. 2007; 8:992–1000. [PubMed: 17660822]
127. Carrasco YR, Batista FD. B cells acquire particulate antigen in a macrophage-rich area at the boundary between the follicle and the subcapsular sinus of the lymph node. Immunity. 2007; 27:160–171. [PubMed: 17658276]
128. Park C, Arthos J, Cicala C, Kehrl JH. The HIV-1 envelope protein gp120 is captured and displayed for B cell recognition by SIGN-R1(+) lymph node macrophages. eLife. 2015; 4
129. Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M, Fink K, Henrickson SE, Shayakhmetov DM, Di Paolo NC, et al. Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007; 450:110–114. [PubMed: 17934446]
130. Heesters BA, Chatterjee P, Kim YA, Gonzalez SF, Kuligowski MP, Kirchhausen T, Carroll MC. Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Immunity. 2013; 38:1164–1175. [PubMed: 23770227]
131. Keele BF, Tazi L, Gartner S, Liu Y, Burgon TB, Estes JD, Thacker TC, Crandall KA, McArthur JC, Burton GF. Characterization of the follicular dendritic cell reservoir of human immunodeficiency virus type 1. J Virol. 2008; 82:5548–5561. [PubMed: 18385252]
Sewald et al. Page 14
Curr